Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Eli Lilly and Company Limited
Lilly House, Priestley Road, Basingstoke, Hampshire, RG24 9NL
Telephone: +44 (0)1256 315 000
Fax: +44 (0)1256 775 858
WWW: http://www.lilly.co.uk
Medical Information e-mail: ukmedinfo@lilly.com
Medical Information Fax: +44 (0)1256 775 569

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 29/07/2011
PIL Cymbalta 30mg hard gastro-resistant capsules, Cymbalta 60mg hard gastro-resistant capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 29/07/2011 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to Further Information section
  • Change of contra-indications
  • Change to side-effects
Updated on 14/02/2011 and displayed until 29/07/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to drug interactions
Updated on 28/10/2010 and displayed until 14/02/2011
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to information about pregnancy or lactation
Updated on 04/10/2010 and displayed until 28/10/2010
Reasons for adding or updating:
  • Change to Further Information section
  • Change to side-effects
  • Change to information about pregnancy or lactation
Updated on 31/07/2009 and displayed until 04/10/2010
Reasons for adding or updating:
  • Change to date of revision
  • Change to instructions about overdose
  • Change to storage instructions
  • Change to side-effects
Updated on 23/04/2009 and displayed until 31/07/2009
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 08/08/2008 and displayed until 23/04/2009
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to dosage and administration
  • Changes to therapeutic indications
Updated on 22/05/2008 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 19/09/2007 and displayed until 22/05/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to instructions about overdose
  • Introduction of new pack/pack size
  • Change to date of revision
Updated on 02/01/2007 and displayed until 19/09/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to side-effects
  • Change to date of revision
Updated on 03/07/2006 and displayed until 02/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
Updated on 15/11/2005 and displayed until 03/07/2006
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 13/01/2005 and displayed until 15/11/2005
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  duloxetine hydrochloride